Bristol Myers Squibb (BMY)

R&D Expense Growth

11.70%

Quarterly · Period ending:

BMY logo

BMY R&D Expense Growth

Latest reported11.70%
BMY Quarterly R&D Growth (QoQ) (0.00% → 11.70%)
High-resolution chart · PNG

BMY r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
11.7025%
2.4362%
2.2943%
-2.0155%
14.311%
-29.2698%
34.4145%
-18.1097%
7.5696%
8.7571%
10.5263%
-0.7086%
-2.7143%
-7.5299%
3.8048%
4.1792%
2.6991%
-13.3103%
-12.5168%
20.2583%
11.6719%
-40.8267%
50.06%
-0.912%
6.3238%
13.656%
51.4514%
4%
-1.7062%
-2.3188%
7.8125%
-47.4333%
94.8%
-34.9297%
23.0621%
-7.028%
28.8565%
-6.9286%
23.0228%
-10.1106%
11.4437%
-40.7098%
69.258%
-39.0086%
82.6772%
-14.55%
20.9563%
-30.5791%
49.6829%
-1.1494%
7.1669%
-6.0988%
2.2581%
-14.0481%
13.775%
-1.1435%
5.8306%
-9.8214%
3.5971%
5.4171%
-1.2834%
-7.4257%
22.5728%
0.2433%
-9.6703%
-13.9073%
28.9024%
1.1097%
-10.6828%
-20.5599%
37.0504%
0.9685%
5.6266%
-10.1149%
8.4788%
6.2252%
-4.5512%
-3.6541%
8.5979%
2.1622%
-1.3333%
-3.2258%
15.8445%
3.0817%
-0.6126%
-3.5451%
10.0813%
-1.6%
7.2041%
-17.305%
24.7788%
7.8244%
10.3158%
-27.37%
22.243%
1.518%
4.9801%
-33.9474%
56.701%
-2.0202%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.